TOBRASONE
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Oct 2025)
What this means for you
This application is over — abandoned 10 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97278997
- Mark type
- Stylized text
- Filed
- 22 Feb 2022
- Published for opposition
- 10 Jan 2023
- Abandoned
- 10 Oct 2025
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for ophthalmological use
Owner
- HARROW IP, LLC, Nashville, TN, US
- EYEVANCE PHARMACEUTICALS LLC, Fort Worth, TX, US
- EYEVANCE PHARMACEUTICALS LLC, Fort Worth, TX, US
Prosecution history
- 10 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2024 — SOU EXTENSION 3 GRANTED
- 08 Aug 2024 — SOU EXTENSION 3 FILED
- 08 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2024 — SOU EXTENSION 2 GRANTED
- 12 Feb 2024 — SOU EXTENSION 2 FILED
- 12 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Sept 2023 — SOU EXTENSION 1 GRANTED
- 06 Sept 2023 — SOU EXTENSION 1 FILED
- 06 Sept 2023 — SOU TEAS EXTENSION RECEIVED
- 29 Aug 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS